Bharat Biotech Covaxin shows 78 percent overall interim efficacy, 100 percent efficacy against severe Covid Ruchika Sharma22 April 2021 11:30 AM ISTHyderabad: Drugmaker, Bharat Biotech, has recently announced phase 3 interim analysis results of COVAXIN. The second interim analysis is based...
Bharat Biotech to expand Covaxin production capacity to 700 million doses annually Ruchika Sharma21 April 2021 10:30 AM ISTHyderabad: Bharat Biotech recently announced that it has scaled up its COVID-19 vaccine Covaxin manufacturing capacity to 700 million doses per...
Serum Institute, Bharat Biotech to get Rs 45.67 billion to boost Covid-19 vaccine production capacity Ruchika Sharma20 April 2021 10:30 AM ISTNew Delhi: India's government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and...
Remdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh Vardhan Ruchika Sharma19 April 2021 12:39 PM ISTNew Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while...
Haffkine Institute secures Govt nod to manufacture Covaxin Ruchika Sharma16 April 2021 3:42 PM ISTMumbai: The Union government has given its permission to the city-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of...
India to have 5 more COVID vaccines by Oct Ruchika Sharma12 April 2021 12:02 PM ISTThese vaccines are Sputnik V vaccine, Johnson and Johnson vaccine, Novavax vaccine, Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.
India to review Bharat Biotech, SII COVID vaccine after blood clot warning: Report Ruchika Sharma10 April 2021 5:31 PM ISTNew Delhi: A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two...
PM Modi takes 2nd dose of Covid-19 vaccine at AIIMS, asks all eligible people to get inoculated Medical Dialogues Bureau10 April 2021 9:45 AM ISTPM Modi has taken Covaxin, India's homegrown vaccine developed by Bharat Biotech.
Clinical Trial for third dose of Covaxin gets DCGI panel okay Ruchika Sharma3 April 2021 12:00 PM ISTNew Delhi: The expert panel of India's drug regulator, DCGI, has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its...
Bharat Biotech Covaxin facility fails to meet CGMP standards: Brazilian regulator Ruchika Sharma1 April 2021 1:31 PM ISTNew Delhi: The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech's Covid-19 vaccine Covaxin into the country after its...
Paraguay gets 1 lakh Covaxin doses from India Ruchika Sharma30 March 2021 1:52 PM ISTParaguay: Paraguay on Monday received a shipment of 1,00,000 doses of India's indigenously developed Covaxin vaccine."Paraguay receives 100,000 doses...
Bharat Biotech, Biovet, Sapigen Biologix ink pact with CSIR-IICT for novel platform technologies, vaccine candidates Ruchika Sharma30 March 2021 1:34 PM ISTHyderabad: Vaccine maker Bharat Biotech, Biovet and Sapigen Biologix on Monday signed a collaborative research agreement with CSIR-Indian...
